(Q28250089)

English

Topical henna for capecitabine induced hand-foot syndrome

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Topical henna for capecitabine induced hand-foot syndrome (English)

0 references

1 reference

chemotherapy-induced acral erythema

1 reference

Idris Yucel

1

0 references

Gonullu Guzin

series ordinal

2

0 references

language of work or name

English

0 references

publication date

April 2008

0 references

published in

Investigational New Drugs

0 references

volume

26

0 references

issue

2

0 references

page(s)

189-92

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10637-007-9082-3

0 references

cites work

Henna (Lawsonia inermis Linn.) inducing haemolysis among G6PD-deficient newborns. A new clinical observation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10637-007-9082-3

retrieved

21 January 2018

Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current Canadian experience with capecitabine: partnering with patients to optimize therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antioxidant and immunomodulatory constituents of henna leaves.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine: nursing implications of a new oral chemotherapeutic agent

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three cases of chemotherapy-induced acral erythema

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17885735

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10637-007-9082-3

0 references

Dimensions Publication ID

1030756446

0 references

PubMed ID

17885735

0 references

ResearchGate publication ID

5957032

0 references

(Q28250089)

Topical henna for capecitabine induced hand-foot syndrome

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)